f434 - rMal d 1 (Apple)
Test details
This test is useful when an apple allergy or PR-10 cross-reactivity are suspected, and to identify the specific molecule that has previously caused a positive result in the associated allergen extract test.
Mal d 1 is a protein found mainly in the skin but also in the flesh of the apple, and belongs to the PR-10 group (Bet v 1 type).
Since the protein is sensitive to heat and proteolysis, peeling the apple or consuming it cooked rather than raw may be an effective way to limit exposure to Mal d 1.
A strong cross-reactivity with the Bet v 1 molecule from birch pollen has been observed.
Within a few minutes of eating an apple, individuals sensitised to Mal d 1 develop symptoms related to oral allergy syndromes (OAS), including itching of the mouth, redness of the oral mucosa or angioedema of the lips, tongue, or throat.
Cross-reactivity may also occur with pears, peaches, and cherries.
Sample type
Serum
Method
ChLIA
Preparation
Fasting for at least 8-12 hours before sampling
Storage conditions
Refer to the Health Service Charter to check storage conditions
Shipping
+2/+8°C
References
Hamilton RG. Allergic sensitization is a key risk factor for but not synonymous with allergic disease. J Allergy Clin Immunol. 2014 Aug;134(2):360-1. doi: 10.1016/j.jaci.2014.02.022. Epub 2014 Mar 31. PMID: 24698318.
Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, et al. EAACI Molecular Allergology User's Guide. Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250. doi: 10.1111/pai.12563. PMID: 27288833.
laboratory analysis
Find other tests
Total tau
This test provides the quantitative determination of total tau protein to support the diagnosis of Alzheimer’s disease.
Phosphorylated Tau (pTau181)
This test provides the quantitative determination of tau protein phosphorylated at threonine 181 (pTau181), to support the diagnosis of Alzheimer’s disease.
Anti–NMDAR Antibodies
Test for the determination of human autoantibodies against NMDAR to support the diagnosis of paraneoplastic neurological syndromes with an intermediate-risk phenotype.
Discover what’s new
Subscribe to the newsletter
Subscribe to our newsletter to be always updated.